scispace - formally typeset
A

Anna Pluzhnikov

Researcher at University of Chicago

Publications -  29
Citations -  3873

Anna Pluzhnikov is an academic researcher from University of Chicago. The author has contributed to research in topics: Population & Genome-wide association study. The author has an hindex of 22, co-authored 29 publications receiving 3632 citations. Previous affiliations of Anna Pluzhnikov include University of Illinois at Chicago.

Papers
More filters
Journal ArticleDOI

A genome-wide search for asthma susceptibility loci in ethnically diverse populations

TL;DR: A genome-wide search in 140 families with ≥2 asthmatic sibs, from three racial groups and report evidence for linkage to six novel regions, including 5p15 (P= 0.0008) and 17p11.1–q11.2 (/> = 0.0015) in African Americans and 11p15 and 19q13 (P =0.0013) in Caucasians and Hispanics.
Journal ArticleDOI

Insulin gene mutations as a cause of permanent neonatal diabetes

TL;DR: Ten heterozygous mutations in the human insulin gene are reported in 16 probands with neonatal diabetes, and it is predicted that they prevent normal folding and progression of proinsulin in the insulin secretory pathway.
Journal ArticleDOI

Rational inferences about departures from hardy-weinberg equilibrium

TL;DR: Results suggest that significant DHW can be expected in relatively small samples of patients over a range of genetic models, and propose a goodness-of-fit test to aid investigators in determining whether a DHW observed in the context of a case-control study is consistent with a genetic disease model.
Journal ArticleDOI

Genome-wide association study of obsessive-compulsive disorder.

S. E. Stewart, +127 more
- 01 Jul 2013 - 
TL;DR: Although no SNPs were identified to be associated with OCD at a genome-wide significant level in the combined trio–case–control sample, a significant enrichment of methylation QTLs and frontal lobe expression quantitative trait loci (eQTLs) was observed within the top-ranked SNPs, suggesting these top signals may have a broad role in gene expression in the brain, and possibly in the etiology of OCD.
Journal ArticleDOI

Genetic variants associated with warfarin dose in African- American individuals: a genome-wide association study

TL;DR: A novel CYP2C single nucleotide polymorphism exerts a clinically relevant effect on warfarin dose in African Americans, independent of CYP 2C9*2 and CYP9*3, and incorporation of this variant into pharmacogenetic dosing algorithms could improve warFarin dose prediction in this population.